Connect Biopharma Holdings Limited
CNTB
$0.7901
-$0.0099-1.24%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 93.71M | 93.71M | 110.24M | 110.24M | 118.30M |
| Total Receivables | 1.05M | 1.05M | 3.56M | 3.56M | 351.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.15M | 2.15M | 2.10M | 2.10M | 3.85M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 53.00K | 53.00K | -- | -- | 54.00K |
| Total Current Assets | 96.96M | 96.96M | 115.90M | 115.90M | 122.55M |
|
|
|||||
| Total Current Assets | 96.96M | 96.96M | 115.90M | 115.90M | 122.55M |
| Net Property, Plant & Equipment | 4.24M | 4.24M | 4.52M | 4.52M | 4.74M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 53.00K | 53.00K | 57.00K | 57.00K | 62.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 33.00K | 33.00K | 96.00K | 96.00K | 24.00K |
| Total Assets | 101.28M | 101.28M | 120.57M | 120.57M | 127.38M |
|
|
|||||
| Total Accounts Payable | 342.00K | 342.00K | 5.70M | 5.70M | 2.21M |
| Total Accrued Expenses | 7.55M | 7.55M | 3.16M | 3.16M | 9.40M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 154.00K | 154.00K | 252.00K | 252.00K | 285.00K |
| Total Finance Division Other Current Liabilities | 413.00K | 413.00K | 513.00K | 513.00K | 13.40M |
| Total Other Current Liabilities | 413.00K | 413.00K | 513.00K | 513.00K | 13.40M |
| Total Current Liabilities | 8.46M | 8.46M | 9.62M | 9.62M | 25.29M |
|
|
|||||
| Total Current Liabilities | 8.46M | 8.46M | 9.62M | 9.62M | 25.29M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 24.00K | 24.00K | 73.00K | 73.00K | 180.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 632.00K | 632.00K | 394.00K | 394.00K | 405.00K |
| Total Liabilities | 9.12M | 9.12M | 10.09M | 10.09M | 25.88M |
|
|
|||||
| Common Stock & APIC | 439.37M | 439.37M | 628.88M | 628.88M | 432.41M |
| Retained Earnings | -345.36M | -345.36M | -531.70M | -531.70M | -329.73M |
| Treasury Stock & Other | -1.85M | -1.85M | 13.30M | 13.30M | -1.19M |
| Total Common Equity | 92.17M | 92.17M | 110.48M | 110.48M | 101.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 92.17M | 92.17M | 110.48M | 110.48M | 101.50M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 92.17M | 92.17M | 110.48M | 110.48M | 101.50M |
|
|
|||||